A-Med Announces Results of US Coronary Artery Bypass Surgery Trial.Business Editors/Health & Medical Writers BIOWIRE2K NOTE: Multimedia assets relating to this story will be available for journalists to download beginning today at www.newstream.com and at www.businesswire.com WEST SACRAMENTO, Calif.--(BW HealthWire)--March 15, 2002 A-Med Systems announced the results of the recently concluded US ABACAB trial. The ABACAB (A-Med Beating Heart Assisted Coronary Artery Bypass Coronary artery bypass Surgical procedure to reroute blood around a blocked coronary artery. Mentioned in: Heart Failure coronary artery bypass, n ) trial studied 147 coronary bypass coronary bypass Surgical treatment for coronary heart disease to relieve angina pectoris and prevent heart attacks. It became widely used in the 1960s. One or more blood vessels—usually an artery in the chest or a vein from the leg—are transplanted to create patients at five centers in the United States August - December 2001. The trial identified the benefits of using A-Med's PARAFLow Right Heart Support System during coronary artery bypass procedures in lieu of a heart-lung machine heart-lung machine, device that maintains the circulation of the blood and the oxygen content of the body when connected with the arteriovenous system; it is also called the pump oxygenator. . Patients with at least one difficult to access coronary artery coronary artery n. 1. An artery with origin in the right aortic sinus; with distribution to the right side of the heart in the coronary sulcus, and with branches to the right atrium and ventricle, including the atrioventricular branches and (posterior or lateral wall vessels) were studied. These patients represent the most challenging coronary bypass cases for cardiac surgeons. Results of the study presented by Drs. David Cheng, Carmelo Otero, Tea Acuff and Jerry Kelley suggested that A-Med's PARAFlow Right Heart Support System maintains patient hemodynamic he·mo·dy·nam·ics n. (used with a sing. verb) The study of the forces involved in the circulation of blood. he stability and may improve the surgeon's target vessel access, allowing for complete coronary revascularization. The trial also indicated that the PARAFlow System may allow these complex cases to be performed as more routine for the cardiac surgeon. The PARAFlow System is currently available for sale in the US. Recent studies have substantiated the numerous advantages of performing beating heart surgery beating heart surgery Cardiology Any cardiovascular procedure, often performed endoscopically, in which the heart is not stopped. See CABG. as opposed to "still-heart" surgery, which requires the use of a heart-lung machine. There are approximately 350,000 coronary artery bypass procedures performed in the US each year. A-Med Systems is based in West Sacramento, CA and is a privately held medical device company. A-Med Systems is dedicated to the development of innovative circulatory support systems, designed to advance the standard of care in cardiac surgery and interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based . Additional information may be found on their web site at www.amed.com. NOTE: Multimedia assets relating to this story will be available for journalists to download beginning today at www.newstream.com and at www.businesswire.com. http://www.businesswire.com/cgi-bin/photo.cgi?pw.031502/bb5 http://www.businesswire.com/cgi-bin/photo.cgi?pw.031502/bb5a |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion